Sean Morris

General Partner at Cultivation Capital

View Live Interactive Profile →

Biography

Sean Morris is a General Partner of Cultivation Capital. His firm profile records over 25 years in medical devices spanning development, manufacturing, testing, regulatory, reimbursement and commercial launch. He was Senior Vice President and General Manager of the Peripheral Vascular Division at AngioDynamics, Inc., founded and led Veniti Medical, whose venous stent was acquired by Boston Scientific in 2018, and was President and CEO of Euphrates Vascular. He is currently President and CEO of Artio Medical and of Amplifi Vascular, Inc. He holds a B.S. in Biochemistry from Missouri State University. The Form D for Cultivation Capital Life Sciences Fund IV, LP names him as a Managing Director of the fund's general partner. No portfolio company is attributed to him as an investment on any page read, so notableInvestments is empty.

Education

Previous Experience

Career Timeline

2018
Veniti Medical, which he founded and led, has its venous stent business acquired by Boston Scientific.
2025
Named as a Director, Promoter and Managing Director in the Form D for Cultivation Capital Life Sciences Fund IV, LP.

Sources & References

Cultivation Capital - Sean Morris ↗Cultivation Capital - Team ↗SEC Form D - Cultivation Capital Life Sciences Fund IV, LP ↗